Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-15 20:21 | 2022-09-02 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $23.82 | 5,000 | $119,108 | 439,358 | -1.1% |
| 2022-09-07 02:52 | 2022-09-01 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $23.27 | 5,000 | $116,359 | 444,358 | -1.1% |
| 2022-08-09 03:03 | 2022-08-04 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $20.00 | 10,000 | $200,004 | 449,358 | -2.2% |
| 2022-07-21 01:17 | 2022-07-18 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $20.00 | 2,600 | $52,001 | 459,358 | -0.6% |
| 2022-07-13 02:52 | 2022-07-08 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $20.00 | 1,242 | $24,840 | 461,958 | -0.3% |
| 2022-07-07 03:58 | 2022-07-01 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | SALE | $20.00 | 1,800 | $36,000 | 463,200 | -0.4% |
| 2021-06-03 03:52 | 2021-06-01 | DAWN | Day One Biopharmaceuticals, Inc. | Grant Papanek Julie | Director | Pharmaceutical Preparations | BUY | $16.00 | 13,000 | $208,000 | 10,735,645 | +0.1% |
| 2016-08-17 01:30 | 2016-08-16 | PTGX | Protagonist Therapeutics, Inc | Papanek Julie | Director | Pharmaceutical Preparations | BUY | $12.00 | 583,333 | $6,999,996 | 2,453,255 | +31.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.